MRNA-2752 by Moderna for Transitional Cell Cancer (Urothelial Cell Cancer): Likelihood of Approval

MRNA-2752 is under clinical development by Moderna and currently in Phase I for Transitional Cell Cancer (Urothelial Cell Cancer).

Dec 22, 2023 - 18:00

MRNA-2752 is under clinical development by Moderna and currently in Phase I for Transitional Cell Cancer (Urothelial Cell Cancer).

Read the original article

Tags:

Previous Article

Imvotamab by IGM Biosciences for Rheumatoid Arthritis: Likelihood of Approval

Cadonilimab by Akeso for Esophageal Squamous Cell Carcinoma (ESCC): Likelihood o...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Inflationary pressure causes drop-off in contract manufacturing M&A

Inflationary pressure causes drop-off in contract manuf...

Jul 29, 2023

AstriVax received €2.5 million government grant for thermostable vaccines

AstriVax received €2.5 million government grant for the...

May 30, 2023

STAT+: Republicans want to crack down on pricey health regulations, but there are major loopholes

STAT+: Republicans want to crack down on pricey health ...

Jun 2, 2023